OVERVIEW

Challenging Cases in Cervix Cancer - 2021 Annual Meeting is organized by American Society for Radiation Oncology (ASTRO).

Course Opens: 01/10/2022
Course Expires: 01/09/2025

Description:
This course presents challenging cases of women with cervix cancer, either due to poorly studied disease subsets (e.g. paraortic nodal disease management and nodal recurrent disease) , newer advances in standard intracavitary brachytherapy( eg hybrid brachytherapy indications and implementation), technically challenging distributions of disease (e.g. IIIA and IVA cervix cancer needing complex interstitial brachytherapy) or newly controversial subjects in when and how radiation therapy should be used and integrated with systemic therapy (e.g. oligometastatic and oligoprogressive recurrent cervix cancer).

Topics of particular interest are how to integrate SAbR with targeted therapy for cervix cancer and use of complex image guided interstitial brachytherapy for locally advanced cervical cancer. The organizers solicited cases from social media (Mednet, chartrounds RO Hub) to engage attendees more thoroughly before, during, and after the session. A significant amount of time is also spent in presenting to engage the audience for cases from their practice that may be helpful for the rest of the attendees to hear.

Learning Objectives:
Upon completion of this activity, participants should be able to:

  • Explain the rationale and choice for radiation therapy in cervix cancer with extensive nodal disease.
  • Determine the best brachytherapy treatment options for assymetric large primary cervical cancers and choice of hybrid brachytherapy technique AND image-based complex interstitial brachytherapy approach for Stage IIIA and IV A cervix cancer.
  • Determine the ideal approach for integrating radiation and systemic therapy for cervix cancer cancer.
Credits

Accreditation
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit
1.25 Certificate of Attendance
This activity was designated for 1.25 AMA PRA Category 1 Credit™.

1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits. 

  • 1.25 AMA PRA Category 1 Credits™
  • 1.25 CME
  • 1.25 Credits
  • TARGET AUDIENCE

    PhysicianSurgeonsOncologistsResidentsNursesTherapistsMedical PhysicistsRadiation OncologistsMedical Oncologists

    SPECIALITIES

    Oncology

    RELATED ONLINE COURSES

    May 25, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut ...
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$180

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$15.20

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$102